KCTBASE

Breast, prostate, and thyroid cancer screening tests and overdiagnosis.

Jung, Minsoo

Current problems in cancer
2017Jan ; 41 ( 1 ) :71-79.

PMID : 28104314

저자 상세정보

Jung, Minsoo - Department of Health Science, Dongduk Women’s University, Seoul, South Korea. Electronic address mj748@dongduk.ac.kr.

ABSTRACT

The purpose of this study was to examine overdiagnosis and overtreatment related to cancer screening and to review relevant reports and studies. A comprehensive search of peer-reviewed and gray literature was conducted for relevant studies published between January 2000 and December 2015 reporting breast, prostate, and thyroid cancer screening tests and overdiagnosis. This study revealed no dichotomy on where screening would lower risk or cause overdiagnosis and overtreatment. Many screening tests did both, that is, at population level, there were both benefit (decreased disease-specific mortality) and harm (overdiagnosis and overtreatment). Therefore, we need to consider a balanced argument with citations for the potential benefits of screening along with the harms associated with screening. Although the benefits and harms can only be tested through randomized trials, important data from cohort studies, diagnostic accuracy studies, and modeling work can help define the extent of benefits and harms in the population. The health care cycle that prompt patients to undergo periodic screening tests is self-reinforcing. In most developed countries, screening test recommendations encourage periodic testing. Therefore, patients are continuing their screening. It is necessary for patients to become wise consumers of screening tests and make decisions with their physicians regarding further testing and treatments. CI - Copyright ??2017 Elsevier Inc. All rights reserved.

Cancer screening, overdiagnosis, overtreatment

링크

PubMed

주제코드

주제명(Target field)

연구대상(Population)

연구참여(Sample size)

대상성별(Gender)

질병특성(Condition Category)

연구환경(Setting)

연구설계(Study Design)

연구기간(Period)

중재방법(Intervention Type)

중재명칭(Intervention Name)

키워드(Keyword)

유효성결과(Recomendation)

This study revealed no dichotomy on where screening would lower risk or cause overdiagnosis and overtreatment.

연구비지원(Fund Source)

근거수준평가(Evidence Hierarchy)

출판년도(Year)

참여저자수(Authors)

대표저자

DOI

10.1016/j.currproblcancer.2016.11.006.

KCD코드

ICD 03

건강보험코드